by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersAdnan Dahdul, MD

All Warning Letters

Adnan Dahdul, MD

Warning LetterOpen

Recipient Name Adnan Dahdul, MD, Adnan Dahdul, MD, 95 Frank B Murray Street Springfield , MA 01103 United StatesIssued Mar 12, 2026Office of Compliance and Biologics Quality

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations3

Issue DateMar 12, 2026

Product TypeBiologics

StatusOpen

Letter Details

Firm: Adnan Dahdul, MD
Location: Recipient Name Adnan Dahdul, MD, Adnan Dahdul, MD, 95 Frank B Murray Street Springfield , MA 01103 United States
FEI Number: N/A
Country: United States
Issue Date: March 12, 2026
Issuing Office: Office of Compliance and Biologics Quality
Product Type: Biologics
Status: Open

Subject

Clinical Investigator/BIMO

Adnan Dahdul, MD FDA Warning Letter, March 12, 2026